The Doctors Company to Acquire ProAssurance
The Doctors Company, the nation’s largest physician-owned medical malpractice insurer, and ProAssurance Corporation (NYSE: PRA), an industry-leading specialty insurer with extensive expertise in medical liability, products liability for medical technology and life sciences, and workers’ compensation insurance, today announced that they have entered into a definitive agreement under which ProAssurance will be acquired by The Doctors Company.
Search
Addressing Pandemic Food Insecurity
During the COVID-19 pandemic, TDC Group, which includes The Doctors Company, Healthcare Risk Advisors, TDC Specialty Underwriters, and Medical Advantage, and its employees stepped up to address food insecurity, which is among the social determinants of health.
Jun 05, 2025
Advancing and Protecting Medical Liability Reforms
TDC Group’s recent medical liability advocacy work has seen success nationwide, with opportunities to enact new reforms in some states, while still facing difficult environments in others.
From
The Doctor’s Advocate
June 02, 2023, Cardiology Magazine
Lessons From Medical Malpractice Claims
Experts from The Doctors Company review a cardiology malpractice case involving improper management of warfarin, examining the key elements of the case to identify risk mitigation strategies.
Social Inflation and Nuclear Verdicts Changing Healthcare
Skyrocketing malpractice verdicts, if left unchecked, will lead to healthcare becoming unaffordable and inaccessible. In this video, Robert White, President of The Doctors Company and TDC Group, explains how social inflation and nuclear verdicts are forcing insurers to evolve to combat plaintiff attorney tactics, and how we’re fighting nationwide to protect doctors and patients.
Video Nov 18, 2022
Challenges for Clinicians After Fall of Roe v. Wade
Sheila Dejbakhsh, MD, MPH, offers her perspective on what the future holds for healthcare professionals and patients in response to the Supreme Court decision in Dobbs v. Jackson Women's Health Organization, to let states determine access to reproductive healthcare.
March 06, 2026, KevinMD
The Future of U.S. Medicine: 10 Healthcare Trends in 2026
Richard E. Anderson, MD, FACP, Chairman and CEO, discusses the forces most likely to affect U.S. healthcare through the coming year.
Video Aug 13, 2018
What to Expect from Litigation: Dr. Del Zotto's Perspective
This video, the second in a series showcasing actual claims experiences and providing physicians with insight about what to expect if they are sued for malpractice, features Dr. Thomas A. Del Zotto. He discusses the claim that was made against him and how the support of his insurer, his attorney, and expert witnesses helped him win his case.
February 14, 2023, Inside Medical Liability Online
Malpractice Case: Could Stronger Post-Op Follow-Up Have Prevented this Infection after Knee Replacement?
This article discusses important lessons learned and risk prevention strategies from a study of hip and knee replacement closed malpractice claims by David L. Feldman, MD, MBA, FACS, Chief Medical Officer, The Doctors Company and TDC Group, and Jacqueline Ross, PhD, RN, CPAN, Coding Director, Department of Patient Safety and Risk Management, The Doctors Company.
Professional Education
Module 3: Safe Prescribing of Opioids and CNS Depressants (Innovations and Smart Approaches in Safe Prescribing)
Learn several new concepts and innovation tips. Learn about the new CDC Guidelines about pain. This program will show how to treat pain, opioid withdrawal, and/or opioid addiction. It will show how to taper opioids and you will learn how to conduct “motivational interviewing.” You will examine multimodal approaches for chronic pain, including physical, psych-behavioral, procedural, and pharmacological modalities. You will be encouraged to use tools for prescribing and tapering opioids and benzodiazepines. You will be provided with an overview of the use of CURES 2.0. Lastly, the program will examine how to best screen patients for use of CNS depressants and marijuana to mitigate the potential for contraindications with opioids. This module consists of seven audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.
